COSMEDERM METHODS AS
Score · fiscal year 2025
57of 100
How to read this: the company is ahead of 64 % of small companies in the same sector in 2025. What does this mean?
Rank: 14,046 of 38,670 · Handel
Profile
Cheetah · Sprinter
High profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 69 and solidity 34 out of 100 among small companies in the same sector in 2025. Methodology
Against the sector
COSMEDERM METHODS AS is 7 points above the median for small companies in the same sector in 2025.
Median score 50 among 36,110 companies.
Against small companies in the same sector in 2025: operating margin 6.6% (median 2.5%) and equity ratio 25.8% (median 38.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 9 MNOK | 3 MNOK |
| Operating margin | 6.6% | 2.5% |
| Profit margin | 6.3% | 2.2% |
| Return on assets | 12.7% | 4.0% |
| Equity ratio | 25.8% | 38.3% |
| Debt-to-equity | 2.88 | 0.99 |
| Current ratio | 1.51 | 1.70 |
| Revenue growth | 35.5% | 3.5% |
| Revenue per employee | 1.15 MNOK | 1.62 MNOK |
The median and “ahead of” refer to small companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 57, COSMEDERM METHODS AS does better than 64% of small companies in the same sector (36,579 companies) in 2025.
Score 2023–2025
- COSMEDERM METHODS AS
- Median: small companies in the same sector
COSMEDERM METHODS AS has a score of 57 for 2025, rank 14,046 of 38,670 in the sector.
Strongest: Growth: percentile 83 against peers, revenue growth 35.5% against a median of 3.5%. Profitability: percentile 69 against peers, operating margin 6.6% against a median of 2.5%.
Weakest: Solidity: percentile 34 against peers, equity ratio 25.8% against a median of 38.3%.
Worth a closer look
- What lies behind weak solidity, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
COSMEDERM METHODS AS had an operating margin of 6.6% and an equity ratio of 25.8% in 2025, and ranks 14,046 of 38,670 in Handel.
From 2024 to 2025: the operating margin fell from 16.7% to 6.6% and revenue grew by 35%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 1 MNOK and 5 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 5 MNOK |
| EV/EBIT | 8.0 | 4 MNOK |
| P/B | 1.0 | 1 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 1.0% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 69 | weight 30% |
|---|---|---|
| Solidity | 34 | weight 25% |
| Liquidity | 45 | weight 15% |
| Growth | 83 | weight 15% |
| Consistency | 58 | weight 15% |
Durability: 45 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is COSMEDERM METHODS AS?
The operating margin was 6.6% in 2025, against a median of 2.5% among small companies in the same sector. Return on assets was 12.7%.
How solid is COSMEDERM METHODS AS?
The equity ratio was 25.8% in 2025 (median 38.3%). Debt-to-equity was 2.88 (median 0.99).
What is the liquidity of COSMEDERM METHODS AS like?
The current ratio was 1.51 in 2025 (median 1.70).
How does COSMEDERM METHODS AS compare in Handel?
COSMEDERM METHODS AS ranks 14,046 of 38,670 in Handel for 2025. Among companies of the same size (small companies) it ranks 13,196 of 36,579. Revenue changed by 35.5% from the year before.
From the Central Coordinating Register
- Org. no.
- 976009940
- Legal form
- AS
- Sector
- Handel (46.450)
- Size tier
- small
- Employees
- 8 registered 10 July 2026
- Founded
- 5 January 1996 30 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Holtegata 30, 0355 OSLO
- Municipality
- Oslo rank 63–221 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chair of the board
- Elsebeth Lund Engzelius
- Board member
- Ingelin Engzelius Harlem
- Deputy member
- Haakon Engzelius
- Auditor
- MOORE AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 28 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 20 | 59 | 57 | |
| Rank | 30,122 | 12,159 | 14,046 | |
| Operating margin | −0.6% | 16.7% | 6.6% | |
| Return on assets | −1.2% | 26.5% | 12.7% | |
| Equity ratio | −10.5% | 18.3% | 25.8% | |
| Current ratio | 1.10 | 1.48 | 1.51 | |
| Revenue growth | – | 12.6% | 35.5% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 6.0 MNOK | 6.8 MNOK | 9.2 MNOK |
| Operating profit | 0.0 MNOK | 1.1 MNOK | 0.6 MNOK |
| Profit before tax | −0.1 MNOK | 1.1 MNOK | 0.6 MNOK |
| Net profit | −0.1 MNOK | 1.1 MNOK | 0.5 MNOK |
| Financial expenses | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Total assets | 3.3 MNOK | 4.3 MNOK | 4.9 MNOK |
| Current assets | 3.3 MNOK | 4.2 MNOK | 4.5 MNOK |
| Equity | −0.3 MNOK | 0.8 MNOK | 1.2 MNOK |
| Retained earnings | −0.6 MNOK | 0.5 MNOK | 1.0 MNOK |
| Total liabilities | 3.6 MNOK | 3.5 MNOK | 3.6 MNOK |
| Current liabilities | 3.0 MNOK | 2.8 MNOK | 3.0 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 28 October 2026, accounts id 7218460.
Further
Similar companies
- MONAS TRADING AS index 57, rank 14,042 · compare
- VITUSAPOTEK GEILO AS index 57, rank 14,044 · compare
- AUTOSENTERET MOLDE AS index 57, rank 14,045 · compare
- SYBERG AS index 57, rank 14,047 · compare
- TRANSTECH AS index 57, rank 14,048 · compare